{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-011717","form_type":"8-K","ticker":"GPCR","cik":"0001888886","company_name":"Structure Therapeutics Inc.","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.345400+00:00","generated_at":"2026-06-19T23:15:30.165397+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Structure Therapeutics adopts restated articles authorizing 500M ordinary shares, effective upon IPO closing","bullets":["Filed restated memorandum and articles on Feb 3, 2023, effective Feb 7, 2023 upon IPO closing.","Authorizes 500,000,000 ordinary shares; details previously reported in Registration Statement on Form S-1.","Seventh amended and restated memorandum and articles of association filed as Exhibit 3.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-011717","json":"https://secwatch.observer/filing/0001104659-23-011717.json","markdown":"https://secwatch.observer/filing/0001104659-23-011717.md","text":"https://secwatch.observer/filing/0001104659-23-011717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/0001104659-23-011717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/tm235639d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T23:15:30.165397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a48519646c0199a86b9437fb24ca6d9db4fc68fa","claim":"Structure Therapeutics Inc.: Filed amended and restated memorandum and articles of association to authorize 500,000,000 ordinary shares, effective upon IPO closing (effective 2023-02-07).","evidence_excerpt":"On February 3, 2023, and in connection with the consummation of Structure Therapeutics Inc.’s (the “Company”) initial public offering of its American Depositary Shares representing its ordinary shares (the “IPO”), the Company filed an amended and restated memorandum and articles of association (the “Restated Memorandum and Articles”), substantially in the form previously filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-269200) (as amended, the “Registration Statement”), with the Registrar of Companies of the Cayman Islands. The Restated Memorandum and Articles each became effective upon the closing of the Offering on February 7, 2023.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1888886/000110465923011717/0001104659-23-011717-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-02-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}